Infectious disease companies develop technologies, diagnostics and therapeutics that prevent, detect and treat bacterial, viral, fungal and parasitic infections. Their work supports global health, outbreak response and disease surveillance.
This category includes companies working on:
Browse 118 UK infectious disease companies below.
Synthetic T cell-priming vaccines and immunotherapies for infectious disease
Gylden Pharma is a clinical-stage biotechnology company developing 100% synthetic T cell-priming vaccines and immunotherapies. Its nanoparticle platform delivers synthetic peptides that stimulate cellular immune responses against intracellular pathogens, providing strain-agnostic protection without cold-chain…
XF-73 antimicrobial advancing towards Phase 3 infection prevention
AMR Bio is a clinical-stage biotechnology company developing the XF-73 antimicrobial platform for preventing hospital-acquired infections. Its lead nasal formulation aims to reduce Staphylococcus aureus carriage before surgery. Following Phase 2b clinical testing, the programme is preparing for Phase 3 development.…
Manufacturer of lateral flow tests, ELISA kits and immunoassay reagents
Biopanda Reagents is an ISO 13485-certified manufacturer of in vitro diagnostic test kits and immunoassay reagents for clinical, veterinary, environmental, and food safety applications. The product range spans lateral flow rapid tests, ELISA kits, real-time PCR kits, and chemiluminescence assays, covering infectious…
Veterinary vaccine R&D and licensing for livestock infectious diseases
Cambivac develops and licenses veterinary vaccine technologies, combining genomic research with traditional virology and molecular approaches. Its documented development programmes include vaccines for foot-and-mouth disease and porcine reproductive and respiratory syndrome, a respiratory disease affecting pigs. The…
Rapid diagnostic test kits for clinical, pharmacy and consumer markets
CIGA Healthcare is an ISO 13485-certified manufacturer of rapid lateral flow diagnostic tests and immunoassay products, supplying pharmacy outlets, health services and retailers across more than 70 countries. Its brand covers point-of-care and over-the-counter tests for pregnancy, infectious disease, cardiac…
Molecular diagnostic PCR, dPCR and NGS kits for clinical laboratories
TRUPCR Europe develops and supplies molecular diagnostic kits and reagents for clinical and research laboratories. Its portfolio includes real-time PCR, digital PCR and next-generation sequencing assays for oncology, haematological malignancies, infectious diseases and antimicrobial resistance. Products also include…
Portable PCR diagnostic platforms and test kits for veterinary use
ZYTCA Animal Health is a veterinary diagnostics company developing portable point-of-care PCR platforms for rapid disease detection in animals. Using isothermal amplification and lateral flow immunoassay technology, its devices deliver qualitative results in under 30 minutes from unextracted clinical samples, with a…
Novel antibiotic-sparing therapeutics for chronic wound care
ONYA Therapeutics is a biotechnology company developing novel pharmaceutical treatments for acute and chronic wounds. The company's pipeline centres on a patented controlled-release drug delivery technology designed to manage wound exudate and reduce reliance on antibiotics, addressing antimicrobial resistance in…
Immunotherapeutics targeting drug-resistant bacterial infections
Centauri Therapeutics is a clinical-stage immunotherapy company developing treatments for life-threatening infectious diseases using its proprietary platform. The technology uses synthetic bifunctional molecules that recruit and redirect naturally occurring anti-glycan antibodies to target pathogens, engaging both…
Engineered hybrid interferon therapeutics for viral and immune-mediated disease
ILC Therapeutics is a pre-clinical biotechnology company developing hybrid interferons, an engineered cytokine drug class combining favourable attributes of multiple naturally occurring interferon subtypes. The platform rationally designs novel candidates with reduced toxicity and pleiotropic activity across multiple…
AI platform designing vaccines against current and future pathogens
Baseimmune is a biotechnology company developing a deep learning platform for computational vaccine antigen design. The platform integrates genomic, epidemiological, immunological, and evolutionary data to generate novel synthetic antigens drawn from across an entire pathogen genome, enabling the design of vaccines…
Inorganic nanoscale immune modulators for infection, cancer and autoimmunity
Iuvantium is a biotechnology company developing therapeutics and vaccines based on inorganic nanoscale materials that modulate the immune system. The company uses tailored inorganic probes to study how the immune system responds, builds a computational model of immune behaviour, and designs programmable immune…
Integrated sample collection and rapid molecular diagnostic devices
ReadyGo Diagnostics develops disposable sample-collection and preparation devices for rapid diagnostic testing. Its technology combines swab collection and lysis chemistry in a single unit and is designed to work with lateral flow, molecular and immunoassay formats. It also supports rapid isothermal molecular tests…
Generic injectable medicines for NHS secondary care
Bowmed Ibisqus is a privately owned pharmaceutical company supplying generic injectable medicines to NHS hospitals and the private healthcare sector. Operating as a marketing authorisation holder and distributor, the company specialises in injectable antibacterials spanning penicillin, cephalosporin, macrolide, and…
Targeted antibacterial gel for gum disease
Sysora Health develops a targeted antibacterial gel for periodontitis, a severe form of gum disease. Its approach aims to eliminate Porphyromonas gingivalis, a bacterium implicated in gum inflammation, while preserving beneficial microorganisms in the oral microbiome. The company is investigating selective bacterial…
Needle-free solid dose vaccine formulation and delivery platform
aVaxMed Limited is a UK biotech developing the aVaxziPen platform, a proprietary needle-free, thermally stable, solid dose vaccine delivery system. The technology encapsulates vaccine antigens into unit solid doses administered via a pen applicator, removing the need for needles and reducing cold chain requirements.…
Precision bacteriocin antibiotics targeting drug-resistant Gram-negative pathogens
Glox Therapeutics is a Scottish biotech developing a pipeline of engineered protein bacteriocins as precision antibiotics against drug-resistant Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. Spun out of the Universities of Glasgow and Oxford in 2023, the company…
IVD manufacturer serving clinical laboratory and transfusion medicine
QuidelOrtho is a global in vitro diagnostics company with a major UK manufacturing and development facility in Pencoed, Wales, employing over 600 people. The site produces immunohematology reagents for transfusion medicine and immunoassay products covering infectious disease, endocrinology, and oncology testing,…
Clinical-stage biopharma targeting cancer immunotherapy and obesity
Poolbeg Pharma is a clinical-stage biopharmaceutical company developing small molecule therapies for high unmet medical needs. Its lead programme, POLB 001, is a p38 MAP kinase inhibitor in clinical trials for prevention of cytokine release syndrome associated with CAR-T and bispecific antibody cancer immunotherapies.…
Specialist virology research services and antiviral testing
Virology Research Services is a UK-based consultancy and experimental service provider specialising in virus research. The company operates state-of-the-art containment level 2 and 3 facilities offering drug screening, antiviral product testing, and bespoke virology research services. Virology Research Services serves…